Patent ID: 11918577
Assignee: FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRONINSTITUT DE RECERCA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 8:
9. A method for the topical eye treatment and/or prevention of glaucoma in a subject in need thereof, comprising administering to said subject a pharmaceutical or veterinary topical eye composition comprising a dipeptidyl peptidase-4 inhibitor selected from the group consisting of sitagliptin, saxagliptin, vildagliptin, linagliptin, anagliptin, teneligliptin, alogliptin, trelagliptin, gemigliptin, omarigliptin, a pharmaceutically acceptable salt thereof, and mixtures thereof, together with a topical pharmaceutically or veterinary acceptable excipient and/or carrier.